Satoh, T., Ishikawa, O., Ihn, H., Endo, H., Kawaguchi, Y., Sasaki, T., Goto, D., Takahashi, K., Takahashi, H., Misaki, Y., Mimori, T., Muro, Y., Yazawa, N., Sato, S., Takehara, K. and Kuwana, M. (2009) Clinical Usefulness of Anti- RNA Polymerase III Antibody Measurement by Enzyme-Linked Immunosorbent Assay. Rheumatology, 48, 1570-1574.
http://dx.doi.org/10.1093/rheumatology/kep290

has been cited by the following article:

• TITLE: Anti-RNA Polymerase III Antibodies in Systemic Sclerosis

  AUTHORS: Andrew Kelly, Chris T. Derk

  KEYWORDS: Autoantibodies, Systemic Sclerosis, Scleroderma, Anti-RNA Polymerase III, Cancer

  JOURNAL NAME: Open Journal of Rheumatology and Autoimmune Diseases, Vol.5 No.3, August 19, 2015

  ABSTRACT: Anti-RNA Polymerase III has been recognized as an important autoantibody in Systemic Sclerosis and it is now included in the 2013 ACR/EULAR classification criteria for Systemic Sclerosis. With this manuscript we attempt to review the current data on anti-RNA polymerase II as it relates to Systemic Sclerosis.